Improves Cognitive Function

An overwhelming body of clinical evidence supports the benefits of Noopept on various areas of cognitive function such as memory, learning, and thinking ability:

• In patients with cognitive disturbances caused by traumas or vascular brain diseases, Noopept improved brain function as evidenced by increased alpha- and beta-rhythms power in the electroencephalogram (EEG).
• Administration of Noopept at a dose of 20 mg daily for 2 months improved cognitive function in patients with stroke and has a high level of safety.
• In several animal models of Alzheimer disease (AD), Noopept protected rat brain cells against amyloid beta toxicity (causative agent of AD) by inhibiting oxidative damage, preventing calcium overload, and suppressing apoptosis (programed cell death).
• Repeated oral administration of Noopept in rats improved learning compared to single dose.
• In a rat model of stroke, Noopept demonstrated both cognition-restoring and neuroprotective properties.
• In normal and Down’s syndrome human brain neurons, Noopept prevented oxidative damage and apoptosis.
• In conscious rats, Noopept administration increased brain activity in the EEG.
• Noopept has the ability to increase the levels of Nerve Growth Factor and Brain Derived Neurotrophic Factor, which is associated with chronic improvement in memory.
• Noopept may help improve cognitive function by enhancing the electrical signals between neurons.
• Noopept at a 1:1 ratio or ten-fold greater appeared to significantly reduce the levels of Lewy bodies (protein clumps causing Parkinson’s disease) in the brain.
• In mice with convulsive disorder, chronic administration of Noopept increased the efficacy of the anticonvulsant drug valproate.
• A study reported that Noopept exerts its neuroprotective effects through its antioxidant and anti-inflammatory properties.
• In rats, Noopept enhanced the transmission of nerve signals in the brain.
• In mice, Noopept completely prevented the development of cognitive disorders induced by scopolamine.
• In rats, Noopept reversed cognitive impairment by increasing the levels of brain-derived neurotrophic factor (BDNF).
• In a mouse model of Alzheimer’s disease, Noopept prevented memory deterioration.
• Studies reported that Noopept can help prevent Alzheimer’s disease by inhibiting the formation of abnormal protein structures in the brain and decrease in the activity of stress-activated mitogen-activated protein kinases (MAPK).
• In mice, injection of Noopept 5 minutes before learning improved long-term memory.
• In rats with stroke, Noopept treatment decreased the infarction area (dead tissue) in the brain.
• In rats, Noopept administration at 5 mg/kg via injections produced cognitive-enhancing effects.
• The administration of 0.5-10 mg/kg of Noopept in rats stimulated one-session learning after single administration, while repeated administration increased the learning ability of rats who failed the initial training in the passive avoidance task (a test that evaluates learning and memory).
• Noopept (GVS-111, N-phenylacetyl-L-prolylglycine ethyl ester) administration at a dose of 0.5 mg/kg 15 minutes before the start of the Morris maze induced significant improvements in long-term memory.
• In rats with compression-induced cerebral ischemia, Noopept administration via injections and oral route improved retrieval of passive avoidance responses.
• A cell study found that Noopept prevented neurodegeneration induced by glutamate and oxidative stress.
• In rats that had cognitive impairment due to lobectomy, a procedure that involves the removal of an entire lobe of the brain, Noopept promoted the restoration of learning and memory.
• A cell study reported that Noopept enhanced the transmission of signals between brain cells.

Fights Anxiety

• Noopept’s cognitive-enhancing abilities also produce anti-anxiety effect according to studies:
• Administration of Noopept in patients with mild cognitive impairment reduced fatigue, anxiety, and irritability.
• In patients with newly diagnosed respiratory tuberculosis, Noopept treatment reduced manifestations of anxiety.
• In rats, Noopept administration was associated with an increase in locomotor activity in the elevated plus-maze test, suggesting an anti-anxiety effect.
• Noopept administration also increased exploratory behavior of rats undergoing open field test, which is indicative of reduced anxiety.
• In mice, administration of Noopept produced modulation of the anxiety level.
• In rats, Noopept reduced the incidence of learned helplessness.
• In mice from different strains, Noopept reduced stress levels as evidenced by increased number of avoidance reactions in stress-inducing slip-funnel test.
• In rats aged 4 days, Noopept reversed signs of stress caused by corticotropin releasing hormone (CRH).
• In inbred mice strains, Noopept administration at 1 mg per kg daily produced anti-anxiety effects on the 7th day.

Improves Mood

Noopept can also help improve mood, making it a potential therapeutic option for certain mental health disorders:

• Long-term Noopept administration (21 days) significantly eliminated the manifestations of learned helplessness compared to the anti-anxiety drug Afobazol.
• Chronic administration (28 days, 0.5 mg/day via injections) of Noopept improved behavior by decreasing the activity of stress-induced kinases (involved in mental disorders) and increasing the levels of BDNF.

In summary, Noopept is a promising compound with potential benefits for cognitive function, anxiety, and mood.  Juulyherb is a trusted source of high-quality Noopept and other pharmacologically active substances, ensuring customers have access to reliable, effective solutions for their health and wellness needs. Whether used in supplements, pharmaceuticals, or other applications, Noopept has the potential to make a meaningful difference in the lives of users. As the demand for natural cognitive enhancers continues to grow, Julyherb remains committed to providing innovative products to meet the ever-changing needs of our customers.